Three of the submissions did not support the proposal highlighting the impact the change in scheduling would have on product currently on the market, industry, pharmacists and consumers. Two submissions noted that there has not been a history of concern with this combination of substances. One submission, referring to the NEJM article, believed that a lack of information about the study means that it cannot be relied upon as there is not a meaningful assessment of the results.
AOD9604 is a peptide fragment (hGH Fragment 177-191) of the C-terminus of Human Growth Hormone to which a tyrosine is added at the N-terminal end.  Studies have suggested that AOD9604 is more effective than its predecessor AOD9401 in its ability to stimulate lipolytic (fat burning) and anti-lipogenic activity. Like Growth Hormone, AOD9604 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis (prevents the transformation of  fatty food materials into body fat) both in laboratory testing and in animals and humans.  Recent  clinical research studies have shown that  AOD9604 did show a reduction of body fat in the mid abdominal area in both obese, over-weight, and average built people.

TGA evaluator concluded that the consistent absence of any clinically meaningful effects on blood pressure (BP) or heart rate (HR) in the applicant's bioavailability studies, and the absence of any ADR reports of BP, HR or other cardiovascular problems, indicate that "there is no valid reason for concern and no need to take any regulatory against the combination products currently in the ARTG and available in the Australian market", i.e. no demonstrated safety risk, and no evidence provided of efficacy of paracetamol 1000 mg / phenylephrine HCl 5 mg adult dose.


The ACMS recommended that Growth Hormone Releasing Hormones (GHRHs), Growth Hormone Secretagogues (GHSs), Growth Hormone Releasing Peptides (GHRPs) as well as new individual substance entries for CJC-1295, ipamorelin, pralmorelin (Growth Hormone Releasing Peptide-2), Growth Hormone Releasing Peptide-6, hexarelin and AOD-9604 be included in Schedule 4.
After the commencement of the active treatment 88.9% of subjects experienced at least one AE, whereby the distribution was similar in the 5 AOD9604 groups and the placebo group. There was a higher incidence (48.4%) of nervous system disorders (mainly headache, 42.6%), gastrointestinal disorders (30.4%, mainly diarrhea unspecified, 9.0%) and infections and infestations (45.3%), than seen before the commencement of active treatment. The distribution of the intensity of AEs was similar across all treatment groups. The percentage of AEs that deemed to be possibly or probably related to the study medication was similar across all treatment groups, including placebo.
Endurobol (GW501516): Classified under a group of drugs called peroxisome proliferator-activated receptor (PPAR) agonists, Endurobol’s potential abuse in athletes is based on animal studies that showed it could improve endurance, increase fat metabolism, improve glucose uptake in skeletal muscle tissue, and increase in muscle gene expression. At the moment, there is insufficient evidence for these sport performance outcomes in humans. Human side-effects are currently also unknown. Endurobol is prohibited both in and out of competition under WADA’s Prohibited List.

Kor Naturals Fat Burner For Men acts as a powerful thermogenic weight-loss supplement, using all natural ingredients that focus on improving metabolic function, preventing hunger cravings, increasing energy, and promoting the natural metabolism of calories and fat. Users love the chemical-free formula, and how simple it is to add this fat burner into your diet routine. Ingredients like Garcinia Cambogia, B Vitamins, and enhanced Caffeine are scientifically researched and proven to help you reach your weight loss goals. On top of being a great fat burning formula, Kor Naturals gives you a 90 day money back guarantee of 100% satisfaction!


The full activation of the hGH-receptor requires dimerization of two receptor molecules by one intact growth hormone molecule. The hGH has two different binding regions, site 1 and site 2, which bind in a sequential manner to two different regions of the receptor. Only if this trimer of one hGH molecule and two receptors is formed, does the subsequent signal transduction pathway become initiated [27, 28]. The hexadecapeptide AOD9604 consists only of amino acids 177-191 of hGH with an additional tyrosine residue at the N-terminus. The binding site 1 of the hGH, which is located in the fourth helix [27], is partially overlapping with the sequence of AOD9604. However, binding site 2 of hGH is completely missing in AOD9604. Therefore, it was hypothesized that AOD9604 is unable to induce dimerization and thereby activation of the receptor. This has been confirmed in previous in vitro experiments. Competition binding assays in cells transfected with the 125I-hGH receptor have shown that AOD9604 is incapable of competing with hGH for binding [20]. In a highly sensitive BaF3 cell proliferation test Heffernan et al (2001) also showed that AOD9604 did not induce cell-proliferation even in very high dosages [20].
In plasma, different isoforms and fragments of hGH were found [10]. Research on specific domains and fractions of the protein revealed that they can be assigned to different actions of the protein: In vitro and in vivo experiments have shown that several fragments of the amino terminal region of hGH, namely 1-15, 1-42, 6-13, and 32-46, exhibit an insulin-potentiating action [14-16]. The region hGH 108-129 was found to evoke high mitogenic responses [17], while the carboxy terminus hGH177-191 seemed to be a lipid mobilizing domain, inhibiting the acetyl-CoA carboxylase activity in adipocytes and hepatocytes [18].
A NOTE ABOUT RELEVANT ADVERTISING: We collect information about the content (including ads) you use across this site and use it to make both advertising and content more relevant to you on our network and other sites. This is also known as Online Behavioural Advertising. You can find out more about our policy and your choices, including how to opt-out here.
Statistical analysis was performed using SPSS version 14.0 (SPSS, Chicago, Ill). The differences of gross morphological and histolopathological findings and lameness period among four groups were assessed using the Kruskal–Wallis test. The Mann–Whitney U test was used to compare the gross morphological and histolopathological findings and lameness period between two groups, and p-values <0.05 were considered statistically significant.
As it is not yet approved for use in this country (or any other), it should always have been considered banned under the S0 category, which states that any pharmacological substance that is not addressed by any of the subsequent sections of the Prohibited List and with no current approval by any governmental regulatory health authority for human therapeutic use (e.g. drugs under pre-clinical or clinical development or discontinued, designer drugs, substances approved only for veterinary use) is prohibited.
Peptide therapy, or the use of specific peptides in treatment, has gained great popularity in recent years. This is due largely to the fact that these peptides are highly specific (i.e., only do what you want them to do) while also being well-tolerated and safe. As of January 2015, there were over 60 US FDA-approved peptide medications, 140 peptide drugs being evaluated in clinical trials, and 500 in pre-clinical development.
In June 2007, the NDPSC decided to extend the exemption from the limit on paracetamol combinations being allowed as general sale products to include phenylephrine (as long as it also qualified as exempt from scheduling through the phenylephrine entries). At that time, the NDPSC considered that the safety profile of these substances was such that allowing a fixed combination to be unscheduled was reasonable.
The duration (treatment and follow up) of the individual studies depended on the type of study (supplementary data). The first three clinical trials were single dose treatments (METAOD001 - METAOD003); the longest was a phase IIb clinical trial (METAOD006) with a four weeks run-in phase, followed by a six months treatment phase and a 30 day follow-up phase.
Great, I just filled a script for ipamorelin yesterday and it will ship today. This will be the 1st time use. I’m 41, 6’1 210 pretty fit, recently had an acl replaced 1.5 yr ago and a wrist surgery, and have some lower back and shoulder pain that I ignore. How long/short could I use this to feel any rebuilding effect. I certainly don’t want bloat, or cancer. I might be able to cancel the order 1st thing this a.m. Thanks.
Ultimately, it needs to be trialled in athletes. But that would never happen. As a substance with no therapeutic use, there is no need to ever test it to determine its effect on athletic performance. You don't need the same standard of evidence for drugs like EPO (synthetic replicas of hormones), where the primary biological effect studied in clinical trials of non-athletes is clearly and blatantly performance enhancing. With something like AOD9604, the waters are much murkier with respect to athletic performance.
Application would result in all current OTC paracetamol/ phenylephrine products being up-scheduled to S3. Applicant’s justification for changing current combination products from exempt or S2 to S3 is on theoretical basis only, and no evidence provided of clinical risk. Pharmacokinetic study found that co-administration of paracetamol with phenylephrine increased plasma phenylephrine levels - applicant says this has potential for cardiac safety risk in susceptible patients.

The amazing effects of HCG on the hypothalamus were discovered by Dr. Albert T. W. Simeons in 1954, who observed that malnourished women tend to give birth to healthy babies with normal birth weights. Dr. Simeons concluded that women are able to do this because the HCG hormone that their bodies naturally produced during pregnancy helped their bodies to metabolise subcutaneous fat. hCG released by the embryo also helps women with weight redistribution (helps prevent uneven deposits of weight on thighs, abdomen, hips etc) and therefore women concerned with hormonal weight gain are ideal candidates for this diet.
What may be unknown to some people is that hormones can come in three classes. We are all familiar with steroid hormones, which are fat soluble hormones that include testosterone, oestrogen, and their derivatives. A lesser known group of hormones are those made from peptides. The best known peptide hormone is human growth hormone (hGH) and insuline-like growth factor 1 (or IGF1), both of which are anabolic hormones that are responsible for cell growth and proliferation. Finally, some single amino acid derivatives can also be classed as hormones. Amino acids such as phenylalanine, tyrosine, and tryptophan can also be biologically modified into hormones.
In lean animals, neither AOD9604 nor hGH had any effect on epididymal white adipose tissue mass or expression ofβ 3-AR RNA, indicating that in lean animals, this fat tissue is not a major target for these drugs in this study. In contrast, the mass of BAT in lean animals was reduced by both hGH and AOD9604, and β3-AR RNA expression was increased by both these compounds. This could possibly suggest that the increased expression of β3-ARs in brown adipocytes sensitizes catecholamines to dissipate heat.

I have a close friend that's wanting to drop some fat before his wedding and honeymoon , I've had him on a solid diet and training regimen for a month now and he is making good progress but I don't think he's gonna be on track with where he wants to be in time. Rather than have him use clen or DNP I'd rather have him use a peptide or something safer.


All studies were performed according the Declaration of Helsinki (as amended in Edinburgh, Scotland, October 2000) and the ICH Guidelines for Good Clinical Practice (GCP) (E6). Further, independent ethics review committees of up to 16 Australian hospitals and medical centers have approved each of them. The two largest studies (METAOD005 and METAOD006) were registered at the Therapeutic Goods Administration’s Clinical Trial Notification (CTN) Scheme in Australia.
For example, there are Growth Hormone Releasing Peptides (GHRP’s with names such as ipamorelin and hexarein) which allow for a slow and steady growth hormone release that produces a pulse which mimics natural growth hormone release times and Growth Hormone Releasing Hormones (GHRH’s such as Mod-GRF) for an even stronger natural release of growth hormone and greater presence of growth hormone precursors known as GH “frags” or fragments.

Causing one to be " hungry as a wolf " and having a strong gastric motility, this 1er injectable peptide is interesting for fitness practitioners who may require support to finish their carefully prepared meals. This sudden increase in appetite that occurs around 20 minutes after the injection is related to the fact that GHRP-6 stimulates the release of a digestive hormone, Ghrelin, which is designed to cause hunger pangs. This makes it a valuable ally in weight gain treatments , which is important.
For Growth Hormone (GH) to perform its anabolic (muscle building) affects it requires the presence of the body's most anabolic hormone: insulin. This is in contrast to GH related fat loss which requires insulin to be absent. However, since GHRP and fast-acting GHRH (Growth Hormone Releasing Hormone) products (i.e. Modified GRF 1-29) still need time to stimulate the body to release GH from the pituitary gland, the insulin spike must come after the injection and not before, otherwise the GH release will be blunted.
There are different things you have to consider when wanting to purchase peptides on the web. In the event that you would prefer not to squander your time and cash and hazard your life to get low quality peptides, dependably settle with the most solid and legitimate peptide provider as this can have a gigantic effect. In the event that despite everything you can’t locate a decent provider of first rate quality peptides, you can request your other’s proposals. You may likewise look at PEPTIDE CLINICS in the event that you need.
The truth is peptides are 100% “legal”. I can’t say this is the case for the professional athlete, as certain peptides are banned in sport – highlighted from the Essendon or Cronulla Sharks saga Nevertheless, for the everyday person like us, using these amino acid chains is no crime. In Australia, regulating guidelines such as the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP No. 17), classify majority of peptides as a Schedule 4 substance, meaning that a prescription is necessary for supply and possession. With its own doctors on board, able to provide a script according to Australian prescribing guidelines, Peptides Online has been a key leader in this field.
×